Mol Cancer Res

• 

  Publication Venue For

  • ATM Regulation of the Cohesin Complex Is Required for Repression of DNA Replication and Transcription in the Vicinity of DNA Double-Strand Breaks..  21:261-273. 2023
  • BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation..  21:91-101. 2023
  • HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase..  19:1699-1711. 2021
  • Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance..  19:1398-1411. 2021
  • The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2..  19:1005-1014. 2021
  • Selective ERBB2 and BCL2 Inhibition Is Synergistic for Mitochondrial-Mediated Apoptosis in MDS and AML Cells..  19:886-899. 2021
  • Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents..  19:249-260. 2021
  • The Long Noncoding RNA NEAT1 Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways..  18:1534-1544. 2020
  • Targeting RET Kinase in Neuroendocrine Prostate Cancer..  18:1176-1188. 2020
  • Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib..  18:968-980. 2020
  • 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells..  18:671-684. 2020
  • A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer..  18:79-90. 2020
  • Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis..  18:130-139. 2020
  • CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP..  17:2042-2050. 2019
  • Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes..  17:1545-1555. 2019
  • E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms..  17:1391-1402. 2019
  • Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity..  17:1235-1240. 2019
  • SPHK1 Is a Novel Target of Metformin in Ovarian Cancer..  17:870-881. 2019
  • Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition..  16:599-609. 2018
  • Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis..  16:554-563. 2018
  • Heat Shock Protein 70 (Hsp70) Suppresses RIP1-Dependent Apoptotic and Necroptotic Cascades..  16:58-68. 2018
  • Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG..  15:1243-1254. 2017
  • Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer..  15:1221-1229. 2017
  • CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC..  15:660-669. 2017
  • Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression..  15:507-520. 2017
  • Development of a Novel c-MET-Based CTC Detection Platform..  14:539-547. 2016
  • The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma..  14:344-353. 2016
  • p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma..  13:584-591. 2015
  • Delineation of a FOXA1/ERα/AGR2 regulatory loop that is dysregulated in endocrine therapy-resistant breast cancer..  12:1829-1839. 2014
  • Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer..  12:924-939. 2014
  • Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide..  12:48-57. 2014
  • CLT1 targets bladder cancer through integrin α5β1 and CLIC3..  11:194-203. 2013
  • A message from the Editor-in-Chief..  10:1513. 2012
  • Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression..  10:1389-1399. 2012
  • Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis..  10:546-557. 2012
  • Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma..  10:208-217. 2012
  • Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers..  9:997-1007. 2011
  • Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes..  8:232-245. 2010
  • Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis..  8:223-231. 2010
  • Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression..  8:145-158. 2010
  • Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer. 2021